Skip to main content
Year archive

Icure Pharmaceutical Incorporation — 2021 filings

All 50 regulatory filings released by Icure Pharmaceutical Incorporation (175250) in 2021, sourced directly from the official regulator.

50 Filings
2021 Period
2021 filings (50)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-16 Korean
권리락(무상증자)
Share Issue/Capital Change
2021-12-03 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-11-23 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2021-11-19 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2021-11-19 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-11-12 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-12 Korean
투자판단관련주요경영사항(도네페질 패취(도네시브패취 87.5 밀리그램/도네시브패취 175 밀리그램) 국내 품목허가 획득)
Regulatory Filings
2021-11-05 Korean
전환청구권행사(제2회차 및 제3회차)
Share Issue/Capital Change
2021-10-26 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-08-31 Korean
수시공시의무관련사항(공정공시)
Regulatory Filings
2021-08-20 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-08-13 Korean
전환청구권행사(제2회차)
Share Issue/Capital Change
2021-08-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2021-08-10 Korean
전환가액의조정(제4회차)
Share Issue/Capital Change
2021-08-02 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-07-15 Korean
기타경영사항(특허권취득)(자율공시)(경피투여용 자외선 경화형 하이드로젤 수지, 하이드로젤 및 이를 포함하는 카타플라스마제)
Regulatory Filings
2021-06-29 Korean
기타경영사항(자율공시)(도네페질 패취 의약품품목허가 승인(수출용))
Regulatory Filings
2021-06-03 Korean
기타경영사항(특허권취득)(자율공시)(도네페질을 유효성분으로 함유하는 경피흡수제제)
Regulatory Filings
2021-05-25 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-05-07 Korean
전환가액의조정(제4회차)
Capital/Financing Update
2021-05-03 Korean
투자판단관련주요경영사항(도네페질패취의 미국 FDA 제1상 임상시험계획 승인)
Regulatory Filings
2021-04-30 Korean
투자판단관련주요경영사항(도네페질 패취 의약품품목허가 신청(수출용의약품))
Regulatory Filings
2021-04-30 Korean
기타경영사항(특허권취득)(자율공시)(생리활성물질 피부 전달용 마이크로 구조체 제조방법)
Regulatory Filings
2021-04-29 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-04-29 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-04-16 Korean
투자판단관련주요경영사항(도네페질 패취 식품의약품안전처 국내 품목허가 신청)
Regulatory Filings
2021-04-13 Korean
투자판단관련주요경영사항(도네페질패취의 미국 FDA 제1상 임상시험계획 (IND) 신청)
Regulatory Filings
2021-03-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-23 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-23 Korean
[기재정정]주요사항보고서(무상증자결정)
Share Issue/Capital Change
2021-03-22 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-19 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-18 Korean
주주총회소집결의
AGM Information
2021-03-16 Korean
주주총회소집공고
AGM Information
2021-03-16 Korean
주주총회집중일개최사유신고
AGM Information
2021-03-16 Korean
권리락(무상증자)
Share Issue/Capital Change
2021-03-05 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2021-02-22 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2021-02-22 Korean
[기재정정]투자판단관련주요경영사항(알츠하이머 치료제로서 도네페질패치의 다국가 제3상 임상시험 Primary Endpoint 결과 [Key results Report수령])
Legal Proceedings Report
2021-02-17 Korean
투자판단관련주요경영사항(알츠하이머 치료제로서 도네페질패치의 다국가 제3상 임상시험 Primary Endpoint 결과 [Key results Report수령])
Regulatory Filings
2021-02-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-03 Korean
증권발행결과(자율공시)(제4회차 CB)
Share Issue/Capital Change
2021-02-02 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2021-01-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2021-01-25 Korean